Quality indicator | Proposed target rates21 | No. (%) of patients |
---|---|---|
Pathologic evaluation protocol | > 90% | 300 (100) |
Pathologic reporting by AJCC guidelines | > 90% | 300 (100) |
Protocol for injection of radiocolloid | > 90% | 300 (100) |
Proper identification of SLN | > 90% | 300 (100) |
SLNB performance in eligible patients | > 80% | 189/242 (78.1) |
SLNB concurrent with lumpectomy/mastectomy | > 80% | 290/300 (96.7) |
Completion ALND for positive SLNB | > 75% | 49/61 (80.3) |
SLNB performance in ineligible patients | < 5% | 0 (0) |
Axillary node positivity rate | 25%–34% | 61/300 (20.3) |
Number of nodes removed | 60%–70% | 236/300 (78.6) |
Axillary recurrence rate at 5 years | < 3% | 1/42 (2.4) |
AJCC = American Joint Committee on Cancer; ALND = axillary lymph node dissection; SLN = sentinel lymph node; SLND = sentinel lymph node dissection.